Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Van Beveren

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Nature|March 20, 1986
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminusL Coussens, C Van Beveren, D Smith, et al.
Science (New York, N.Y.)|March 12, 1993
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activationJ M Pongubala, C Van Beveren, S Nagulapalli, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Gene therapy approaches to enhance antitumor immunityD L Shawler, H Fakhrai, C Van Beveren, et al.
Physics in Medicine and Biology|April 8, 2021
Brachytherapy treatment verification using gamma radiation from the internal treatment source combined with an imaging panel-a phantom studyG P Fonseca, T van Wagenberg, R Voncken, et al.
Biochemical Society Symposium|January 1, 1986
Structural features of growth factor receptors with oncogenic potentialE Chen, L Coussens, Y C Liao, et al.
Molecular and Cellular Biology|February 1, 1996
Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2B S Yang, C A Hauser, G Henkel, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2019
A comparison study between single- and dual-energy CT density extraction methods for neurological proton monte carlo treatment planningB van der Heyden, I P Almeida, G Vilches-Freixas, et al.
Genes & Development|September 1, 1990
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequenceF D Karim, L D Urness, C S Thummel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Construction and characterization of retroviral vectors for interleukin-2 gene therapyH Fakhrai, D L Shawler, C Van Beveren, et al.
Clinical and Experimental Immunology|July 9, 2002
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineD L Shawler, R M Bartholomew, M A Garrett, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Nature|March 20, 1986
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminusL Coussens, C Van Beveren, D Smith, et al.
Science (New York, N.Y.)|March 12, 1993
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activationJ M Pongubala, C Van Beveren, S Nagulapalli, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Gene therapy approaches to enhance antitumor immunityD L Shawler, H Fakhrai, C Van Beveren, et al.
Physics in Medicine and Biology|April 8, 2021
Brachytherapy treatment verification using gamma radiation from the internal treatment source combined with an imaging panel-a phantom studyG P Fonseca, T van Wagenberg, R Voncken, et al.
Biochemical Society Symposium|January 1, 1986
Structural features of growth factor receptors with oncogenic potentialE Chen, L Coussens, Y C Liao, et al.
Molecular and Cellular Biology|February 1, 1996
Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2B S Yang, C A Hauser, G Henkel, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2019
A comparison study between single- and dual-energy CT density extraction methods for neurological proton monte carlo treatment planningB van der Heyden, I P Almeida, G Vilches-Freixas, et al.
Genes & Development|September 1, 1990
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequenceF D Karim, L D Urness, C S Thummel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Construction and characterization of retroviral vectors for interleukin-2 gene therapyH Fakhrai, D L Shawler, C Van Beveren, et al.
Clinical and Experimental Immunology|July 9, 2002
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineD L Shawler, R M Bartholomew, M A Garrett, et al.
Pageof 4